Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
706 Conditional cytokine therapeutics for tumor-selective biological activity: preclinical characterization of a dual-masked IFN-a2b
Compose a Response to This Article
Other responses
No responses have been published for this article.